Manuscripts

November 2, 2020

Improving Cancer Data Interoperability: The Promise of the mCODE (Minimal Common Oncology Data Elements) Initiative

JCO Clinical Cancer Informatics
Osterman T et al

Abstracts

August 7, 2022

Long term survival outcomes in NSCLC patients with targeted therapy and immunotherapy: An IASLC analysis of ASCO CancerLinQ Discovery data

World Conference on Lung Cancer 2022
Behera M et al
June 3, 2022

Comparison of DNA sequencing, immunohistochemistry, and in-situ hybridization techniques to determine HER2 status in metastatic breast cancer patients

ASCO Annual Meeting 2022
Lal LS et al
June 3, 2022

Disparities in timely treatment among lung cancer patients

ASCO Annual Meeting 2022
Chhabra J et al
June 3, 2022

Machine learning modeling of real-world primary resistance and hyperprogression in immune checkpoint inhibitor (ICI) treated advanced non-small cell lung cancer (aNSCLC) patients

ASCO Annual Meeting 2022
Das R et al
June 3, 2022

Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials

ASCO Annual Meeting 2022
Bhandari S et al
June 3, 2022

Identifying genetic factors of response and resistance to CDK4/6 inhibitors in metastatic HR+/HER2- breast cancer using real-world data

ASCO Annual Meeting 2022
Agrawal S et al
June 3, 2022

Impact of trial site selection on minority patient recruitment in prostate cancer trials

ASCO Annual Meeting 2022
Lagor C et al
June 3, 2022

Characterizing node-negative non-small cell lung cancer patients with similarity networks: A CancerLinQ Discovery analysis

ASCO Annual Meeting 2022
Moen EL et al
June 3, 2022

Diagnosed with advanced prostate cancer: A population-based cohort from national oncology practices

ASCO Annual Meeting 2022
Kim SP et al